Canada markets closed

Context Therapeutics Inc. (6K9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.2500+0.0800 (+6.84%)
At close: 08:13AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
17,783
17,783
7,091
3,805
1,642
Selling General and Administrative
7,290
7,290
7,790
3,633
930.667
Total Operating Expenses
25,073
25,073
14,881
7,438
2,572
Operating Income or Loss
-25,073
-25,073
-14,881
-7,438
-2,572
Interest Expense
-
-
-
64.24
661.224
Total Other Income/Expenses Net
-55.57
-55.57
-502.004
-2,955
9,878
Income Before Tax
-23,964
-23,964
-14,836
-10,457
6,644
Income from Continuing Operations
-23,964
-23,964
-14,836
-10,457
6,644
Net Income
-23,964
-23,964
-14,836
-10,457
6,644
Net Income available to common shareholders
-23,964
-23,964
-14,836
-10,457
1,071
Basic EPS
-1.30
-1.50
-0.93
-3.69
0.10
Diluted EPS
-1.30
-1.50
-0.93
-3.69
-0.80
Basic Average Shares
15,966
15,966
15,966
2,834
10,210
Diluted Average Shares
15,966
15,966
15,966
2,834
10,210